{
  "anumber": "A56064388",
  "id": "A56064388_0026",
  "page_index": 26,
  "resources": {
    "full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A56064388_0026/full/max/0/default.jpg"
  },
  "fields": {
    "doctype": {
      "ms_doctype_v1": "form"
    },
    "form_title": {
      "ms_form_title_llm_v1": "Paperwork Reduction Act and Privacy Act Notices, DS-3026"
    },
    "years": {
      "ms_years_nlp_v1": [
        2023
      ]
    }
  },
  "is_g325a": false,
  "is_cert_naturalization": false,
  "full_text": "Screened by NARA, 8/11/2023 3. Additional Testing Needed Prior to Approving Medical Clearance No Yes Physical examination or results Referral prior to departure laboratory If yes, provide results contradict EKG medical history VENTRICLE EXTRASYPTIC LEFT VENTRICLE H y PERTROPHY Referral prior to departure If yes, provide results DIFFUSE Taos BLE oF with SYSTOLIC OVERLOAD REPOLARIZATION SUB ENDOCARDIAC RN FARET 4. Follow-up Needed After Arrival No Yes, within 1 week Yes, within 1 month Yes, within 6 months For list continuing medication, type, dose, and frequency NIFED,DINE-R 20mg DAY For continuing other treatment, specify AJA 80 my 1DAY METOPROCILL 50mg/DAY 5. Remarks (describe abnormal findings, and resulting interventions) His any abnormal TORY history, oF HIGH Blood PRESSURE B12 ATERAL CATAMAT MO DECATE \"ARAFNESS, DENTAL CARIES AND CAURIES PAPERWORK REDUCTION ACT AND PRIVACY ACT NOTICES Public reporting burden for this collection of information is estimated to average 35 minutes per response, including time required for searching existing data sources, gathering the necessary data, providing the information required, and reviewing the final collection. Persons are not required to provide this information in the absence of a valid OMB approval number. Send comments on the accuracy of this estimate of the burden and recommendations for reducing it to: Department of State (A/RPS/DIR) Washington, DC 20520-1849. We ask for information on this form, in the case of applicants for immigrant visas, to determine medical eligibility under INA Sections 212(a) and 221(d), and, in the case of refugees, as required under INA Section 412(b)(4) and (5). If an immigrant visa is issued or refugee status granted, you will convey this form to the INS for disclosure to the Center for Disease Control and the US Public Health Service. Failure to provide this information may delay or prevent the processing of your case. If an immigrant visa is not issued or refugee status is not granted, this form will be treated as confidential under INA Section 222(f). Page 2 of 2 DS-3026 INAREP"
}